Skip to Main Content

Featured Stories

Jack: Lung Cancer Survivor

Eight years since his treatment for lung cancer in a clinical trial that combined two immunotherapy drugs: nivolumab, an anti-PD-L1 blocker, and ipilimumab, an anti CTLA4 inhibitor, Jack White has remained cancer free.

Cindy: Lung Cancer Survivor

Mrs. Bartley developed a persistent cough. A former smoker, she became worried when she started coughing up blood. Her primary care physician ordered scans that detected a node on her right lung. After an endoscopy, she was diagnosed with non-small cell lung cancer.

Ten Years of Leadership in Immunotherapy

The last several years have been packed with revolutionary developments in immunotherapy, the decade’s biggest breakthrough in cancer treatment. Yale scientists have played leading roles in that story. Despite the tremendous progress, big challenges remain.

Vaping: A Huge Uncontrolled Experiment

E-cigarettes deliver their nicotine load into the lungs and include appealing flavors. Recent studies suggest that teenagers who would not otherwise have started smoking have been enticed back to tobacco products by e-cigarettes.

Bob: Lung Cancer Survivor

When Bob was diagnosed with stage IV metastatic lung cancer it had spread to his lymph nodes, esophagus, and brain.

Maureen: Lung Cancer Survivor

Maureen was started on a new clinical trial testing the efficacy of a drug known as an anti-PD1 therapy.

Making Waves Against Lung Cancer

When Anita was diagnosed with stage IV non-small cell lung cancer (NSCLC), she was told there was nothing that could be done, that is until she came to Yale Cancer Center.

Looking Beyond Lung Cancer

Bob Carlson cannot describe what a symptom of cancer feels like, even though he was diagnosed with stage IV lung cancer.

Unleashing the Immune System to Fight Cancer

Unlike chemotherapy and other targeted treatments, nivolumab fights cancer by harnessing the body’s immune system.

Linda: Lung Cancer Survivor

Linda commented that she was treated with respect, and also warmth and compassion and that made a huge difference. She sees the members of the Thoracic Oncology Program as her heroes.

Building a Powerhouse Team to Tackle Lung Cancer

Dr. Roy S. Herbst realized that he not only needs to persevere against lung cancer – he needs to inspire a team of talented scientists to do the same.

Smilow Shares Greenwich: Advances in Lung Cancer Screening and Treatment

Roy S. Herbst, MD, PhD - Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; Associate Cancer Center Director for Translational Research, Yale Cancer CenterJustin Blasberg, MD, MPH, FACS - Associate Professor of Surgery (Thoracic) Anne Chiang, MD, PhD - Associate Professor of Medicine (Medical Oncology) Vincent Mase, Jr., MD - Assistant Professor of Surgery (Thoracic) Bruce McGibbon, MD - Assistant Professor of Clinical Therapeutic Radiology

Watch video